Recombinant TNF alpha (Infliximab Biosimilar) antibody
-
- Target See all TNF alpha (Infliximab Biosimilar) products
- TNF alpha (Infliximab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Chimeric
-
Conjugate
- This TNF alpha (Infliximab Biosimilar) antibody is un-conjugated
-
Application
- Flow Cytometry (FACS), In vivo Studies (in vivo), ELISA
- Purpose
- Anti-TNF alpha [cA2 (Infliximab)], Mouse IgG2a, kappa
- Specificity
- Binds to soluble and transmembrane forms of TNF-alpha and neutralizes its biological activity. Does not bind to TNF-beta.
- Characteristics
-
Original Species of Ab: Human
Original Format of Ab: IgG1
- Purification
- Protein A affinity purified
- Immunogen
- Purified recombinant human TNF (rTNF).
- Clone
- CA2
- Isotype
- IgG2a kappa
-
-
- Application Notes
- This antibody can be used to detect and neutralize human TNF alpha. Unlike Adalimumab (Ab00718), Infliximab does not bind to mouse TNF alpha (Arnoult 2017, PMID: 28584008).
- Comment
-
This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.
- Restrictions
- For Research Use only
-
- Concentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % Proclin 300.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Target
- TNF alpha (Infliximab Biosimilar)
- Abstract
- TNF alpha (Infliximab Biosimilar) Products
- Target Type
- Biosimilar
- Background
- TNF-α, TNFα, TNFSF, Tumor necrosis factor, Cachectin, TNF-alpha, Tumor necrosis factor ligand superfamily member 2, TNF-a, TNFa
- UniProt
- P01375
-